Adelene Perkins, chair, president and chief executive officer at Infinity AbbVie ($ABBV) has agreed to hand over $275 million upfront to Infinity Pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback